Data mining and drug safety (created 2006-05-04).

I am very interested in safety issues, especially in the continuing review/interim analysis of clinical trials. It turns out that S-plus is targeting drug safety as a particularly important application of its data mining modules. Two recent web seminars addressed this topic:

This webpage was originally published at the StATS website, which is currently unavailable. There is a dispute about the ownership of these pages, so I am only able to include a brief excerpt from this page.

This work is licensed under a Creative Commons Attribution 3.0 United States License. This page was written by Steve Simon and was last modified on 2008-11-10. Need more information? I have a page with general help resources. You can also browse for pages similar to this one at Category: Adverse events in clinical trials.